Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors
Top Cited Papers
Open Access
- 31 October 2005
- journal article
- research article
- Published by Elsevier
- Vol. 8 (4) , 299-309
- https://doi.org/10.1016/j.ccr.2005.09.005
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Antiangiogenic Therapy of Cerebral Melanoma Metastases Results in Sustained Tumor Progression via Vessel Co-OptionClinical Cancer Research, 2004
- Regulation of angiogenesis by hypoxia: role of the HIF systemNature Medicine, 2003
- The biology of VEGF and its receptorsNature Medicine, 2003
- Immune Enhancement of Skin Carcinogenesis by CD4+ T CellsThe Journal of Experimental Medicine, 2003
- Hypoxia promotes invasive growth by transcriptional activation of the met protooncogeneCancer Cell, 2003
- Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivoOncogene, 2002
- Effects of Angiogenesis Inhibitors on Multistage Carcinogenesis in MiceScience, 1999
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisPublished by Elsevier ,1996
- Biological Activity and Phosphorylation Sites of the Bacterially Expressed Cytosolic Domain of the KDR VEGF-ReceptorBiochemical and Biophysical Research Communications, 1994
- RAG-1-deficient mice have no mature B and T lymphocytesCell, 1992